Fuller & Thaler Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,659
Closed -$328K 629
2018
Q2
$328K Hold
5,659
﹤0.01% 381
2018
Q1
$294K Sell
5,659
-17,397
-75% -$940K ﹤0.01% 385
2017
Q4
$1.24M Hold
23,056
0.01% 303
2017
Q3
$1.41M Sell
23,056
-12,576
-35% -$762K 0.02% 269
2017
Q2
$2.18M Hold
35,632
0.03% 224
2017
Q1
$2.16M Buy
35,632
+21,379
+150% +$1.3M 0.03% 205
2016
Q4
$801K Hold
14,253
0.01% 267
2016
Q3
$849K Buy
14,253
+1,258
+10% +$73.6K 0.01% 250
2016
Q2
$714K Hold
12,995
0.01% 254
2016
Q1
$656K Buy
+12,995
New +$636K 0.01% 253
2015
Q3
Sell
-27,353
Closed -$1.49M 720
2015
Q2
$1.49M Sell
27,353
-3,563
-12% -$200K 0.04% 242
2015
Q1
$1.7M Buy
30,916
+29,239
+1,744% +$1.66M 0.05% 227
2014
Q4
$91K Sell
1,677
-10,794
-87% -$601K ﹤0.01% 503
2014
Q3
$705K Sell
12,471
-17,083
-58% -$959K 0.03% 294
2014
Q2
$1.63M Sell
29,554
-3,877
-12% -$212K 0.07% 230
2014
Q1
$1.81M Buy
33,431
+19,388
+138% +$1M 0.09% 214
2013
Q4
$671K Hold
14,043
0.04% 279
2013
Q3
$638K Sell
14,043
-32,593
-70% -$1.49M 0.04% 279
2013
Q2
$2.07M Buy
+46,636
New +$2.08M 0.15% 191

Other funds holding MRK

Fuller & Thaler Asset Management's MRK Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of Merck (MRK) in Q3 2018, closing a stake of 5,659 shares — an estimated $328K sold.

Fuller & Thaler Asset Management first reported a position in MRK in Q2 2013 and held it in 19 quarters. The position peaked at $2.18M in Q2 2017. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Fuller & Thaler Asset Management reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 5,659 Merck shares in Q3 2018, an estimated $328K.
  • Fuller & Thaler Asset Management first reported a position in Merck in Q2 2013 and held it in 19 quarters.
  • Fuller & Thaler Asset Management's Merck position peaked at $2.18M in Q2 2017.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.